Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen 1 mL per vial
Storage Conditions
-70°C or colder
Comments
This isolate was identified as C. pneumoniae by culture characteristics, morphology of inclusion bodies, and reaction with monoclonal antibodies by depositor. Item isolated on cycloheximide-treated HeLa 229 cells, and found to be serologically identical to the reference strain TW183 by micro-immunofluorescent test.
Effect on Host
Intracellular glycogen negative inclusion bodies visualized by fluorescent staining
Recommended Host
HEp-2 (ATCC® CCL-23™)
Growth Conditions
Temperature: 36°C Recommendations for Infection: Plate cells 24 hours prior to infection and infect when cultures are 80-95% confluent. Vortex material with 1mm glass beads to disrupt cells. Remove cell growth medium and inoculate with disrupted material. Centrifuge at 1500 x g at 25°C for 1 hour. End adsorption by adding agent growth medium. Incubation: 3 days
Name of Depositor
KH Wong, Centers for Disease Control and Prevention
Special Collection
NCRR Contract
Source
Sputum of pneumonia patient, Georgia
References
Black CM, et al. Antigenic variation among strains of Chlamydia pneumoniae. J. Clin. Microbiol. 29: 1312-1316, 1991. PubMed: 1885727
